Deborah Morosini, EVP, Chief of Clinical Affairs at Prelude Therapeutics Inc (PRLD), sold 100 shares at $40.00 ($4K) on 2021-04-08, disclosed to the SEC on 2021-04-15.
Scheduled sale ($4k) by EVP, Chief of Clinical Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PRLD | SELL | 2021-04-30 | $260K | — | Filing → |
| PRLD | SELL | 2021-04-09 | $40K | — | Filing → |
| PRLD | BUY | 2020-09-29 | $8K | — | Filing → |